Cadrenal Therapeutics, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
CVKD on Nasdaq
Location
822 A1 A North, Suite 300, Ponte Vedra, FL

There are no Buy or Sell transactions made by insiders since 11/4/2023

Cadrenal Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Quang Pham CEO and Chairman, Director, 10%+ Owner $4.33M Apr 10, 2024
John R. Murphy Director $424K Jan 18, 2024
Matthew K. Szot Chief Financial Officer $345K Jan 18, 2024
Glynn Wilson Director $34.5K Jan 18, 2024
Steven Zelenkofske Director $27.6K Jan 18, 2024
Douglas W. Losordo Chief Medical Officer Jan 18, 2024
Robert Lisicki Director Jan 18, 2024
Jeffrey Scott Cole Chief Operating Officer Apr 2, 2024

Recent Insider Transactions by Companies or Individuals for Cadrenal Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.